Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Robert H.I. Andtbacka, Merrick Ross, Igor Puzanov, Mohammed Milhem, Frances Collichio, Keith A. Delman, Thomas Amatruda, Jonathan S. Zager, Lee Cranmer, Eddy Hsueh, Lisa Chen, Mark Shilkrut, Howard L. Kaufman

Research output: Contribution to journalArticlepeer-review

237 Scopus citations

Fingerprint

Dive into the research topics of 'Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Biochemistry, Genetics and Molecular Biology